1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
654839EFF8E5F5026002586090038BC89
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew!SearchView&Query=(Field ph=T and FIELD+publishdate+>=+11/02/2003)+AND+(the)+and+(field+ItemCatalog=DB)&SearchWV=1&SearchFuzzy=0&SearchOrder=1&Start=1&Count=10
18
19SearchView&Query=(Field%20ph=T%20and%20FIELD%20publishdate%20%3E=%2011/02/2003)%20AND%20(the)%20and%20(field%20ItemCatalog=DB)&SearchWV=1&SearchFuzzy=0&SearchOrder=1&Start=1&Count=10
203.228.10.64
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Search Results

Results 1 - 10 of 559 Total Hits, .

    |    

DB Image

Library Services Staffing MetricsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Library Services Staffing Metrics" STUDY OVERVIEW Company libraries provide valuabl... (ID 5329)
Companies Profiled: Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, Eisai, Eli Lilly, more ...

DB Image

Cariprazine: The Market Landscape for a Second-Generation Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

STUDY OVERVIEW This short case study examines cariprazine, a second-generation atypical antipsychotic therapy developed by Forest Laboratories and Gedeon Richter... (ID 5302)
Companies Profiled: Forest Laboratories, Gedeon Richter Ltd.

$200.00

DB Image

Driving Pharma R&D Quality Excellence: Key Findings, Top Challenges and Lessons LearnedDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains a practice summary Matrix.

Study Overview Leading pharmaceutical companies seek to achieve and maintain world-class excellence in all aspects of pharmaceutical quality from research and development to manufacturing... (ID 4594)
Companies Profiled: Bristol-Myers Squibb, Sanofi-aventis, Abbott Laboratories, Amgen, more ...

$492.95

DB Image

Key Factors in Conducting Successful Co-PromotionsDirect access to this research is not included with your membership level.This is a pharma specific study.

Study Overview The ability of two companies to integrate themselves into a working alliance ultimately drives the success of a co-promotion effort... (ID 4683)
Companies Profiled: Abbott, Sanofi-aventis, Daiichi Pharmaceutical Co., AstraZeneca, more ...

$430.95

DB Image

Keys to Marketing Management in Pharmaceutical Co-PromotionsDirect access to this research is not included with your membership level.This is a pharma specific study.

Study Overview An effective marketing strategy in a pharmaceutical co-promotion effort lays the foundation for the successful sales of a product... (ID 4668)
Companies Profiled: Abbott, Sanofi-aventis, Daiichi Pharmaceutical Co., AstraZeneca, more ...

$687.95

DB Image

Using Disease Management Systems to Thwart Generic Competitors: A Case StudyDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Companies seeking to develop strategies and tactics that enhance the post-patent success of products can learn from products that maintained market share in the face of generic competition... (ID 4246)
Companies Profiled: Novartis

$574.95

DB Image

Key Factors in Successful Global Pharmaceutical LaunchesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Integrated global marketing launch systems generate rapid sales uptake and help produce blockbuster products that realize their maximum economic potential in the global marketplace... (ID 4564)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline, more ...

$274.95

DB Image

U.S. Pharmaceutical State Government Affairs: Benchmarking the Resources Required to Ensure Brand Market AccessDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to sign-up for a complimentary tour of "U... (ID 4912)
Companies Profiled: GlaxoSmithKline, Elli Lilly, Roche, Bristol-Myers Squibb, more ...

DB Image

Resources Required to Manage Winning Commercial Operations in U.S. Pharmaceutical FinanceDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.

Non-members: Click here to sign-up for a complimentary tour of "Resources Required to Manage Winning Commercial Operations in U... (ID 4911)
Companies Profiled: Roche, Biogen Idec, GlaxoSmithKline, Sigma-Tau, more ...

$1415.00

DB Image

Global Trends in E-detailingDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.

Study Overview Based on a survey of nine pharmaceutical organizations, this 17-slide presentation measures the type and prevalence of e-detailing act... (ID 4574)
Companies Profiled: AstraZeneca, Axcan Pharma, Janssen Cilag Pharmaceutical, Datapharm, more ...

$299.95